Exopharm Limited has appointed Alison Mew as Interim Director of Manufacturing and Development. She will join the senior management team directly reporting to Managing Director Dr. Ian Dixon. She will assume responsibilities for product and process development operations and for preparing a strategy to build Exopharm's manufacturing scale. Alison held senior Operations Management and General Management roles across several divisions of CSL Ltd. during the 13 years she was with the company, including flu vaccine and antivenom manufacture. Executive roles as COO and then CEO of Genetic Technologies Ltd. and consulting in manufacturing operations, strategy and quality to biotechnology companies across Asia Pacific with Centre for Biopharmaceutical Excellence (CBE) have extended her experience. Alison Mew will continue in her roles as Director at Centre for Biopharmaceutical Excellence Pty Ltd. and Non-Executive Director at McPherson Ltd.